Intra-amniotic prostaglandin administration — A challenge to the currently used methods for induction of midtrimester abortion
- 1 August 1973
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 8 (2) , 113-131
- https://doi.org/10.1016/0010-7824(73)90119-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Therapeutic Abortion by Intra-amniotic Injection of ProstaglandinsBMJ, 1972
- Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2αProstaglandins, 1972
- Intravenous prostaglandin F2α for therapeutic abortion: The efficacy and tolerance of three dosage schedulesAmerican Journal of Obstetrics and Gynecology, 1972
- INTRAUTERINE ADMINISTRATION OF 15 (S)-15-METHYL-PROSTAGLANDIN F2α FOR INDUCTION OF ABORTIONThe Lancet, 1972
- Joint Program for the Study of Abortion (JPSA): Early Medical Complications of Legal AbortionStudies in Family Planning, 1972
- Midtrimester abortion using intraamniotic prostaglandin F2αProstaglandins, 1972
- Induction of abortion by intra-amniotic administration of prostaglandin F2αContraception, 1971
- Induction of Midtrimester Abortion by Intra-Amniotic Administration of Prostaglandin F2αA Preliminary ReportActa Physiologica Scandinavica, 1971
- SECOND TRIMESTER ABORTION WITH SINGLE INTRA-AMNIOTIC INJECTION OF PROSTAGLANDINS E2 OR F2αThe Lancet, 1971
- Abortifacient activity of intravenously administered prostaglandinsContraception, 1971